TC-1/A2

Case ID:
C04953
Disclosure Date:
4/6/2006
Description:

TITLE:  TC-1/A2 cell line

CASE NUMBER:    C04953

TECHNOLOGY
JHU Scientists characterized the ability of DNA-encoding calreticulin linked to DNA-encoding E7 antigen to generate HLA-A2-restricted E7-specific CD8+ T-cell responses in HLA-A2 (AAD) transgenic mice, as well as antitumor effects against an E7+ HLA-A2+ tumor cell line, TC-1/A2.

TECHNICAL DETAILS
Scientists at JHU transduced TC-1, an established E7-expressing tumor cell line, with a retrovirus encoding the HLA-A2 (AAD) molecule. The expression of HLA-A2 in the TC-1/A2 cells was confirmed by flow cytometry analysis using an antibody against HLA-A2. Characterization of HLA-A2 (AAD)-expressing TC-1 cells (TC-1/A2) was done by:
(a) Intracellular cytokine staining followed by flow cytometry analysis to determine activation of E7 (aa11–20)-specific CD8+ T cells by TC-1/A2 cells and,
(b) CTL assay to demonstrate specific killing of TC-1/A2 cells by E7 (aa11–20)-specific CD8+ T cells.

TC-1/A2, but not TC-1, was able to activate HLA-A2-restricted E7 (aa11–20)-specific CD8+ T cells in splenocytes from pcDNA3-CRT/mtE7 (del aa49–57)-vaccinated HLA-A2 (AAD) transgenic mice. CTL assays showed specific lysis occurred in TC-1/A2 cells but not in TC-1 cells. The data suggest that TC-1/A2 tumor cells are capable of processing and presenting the E7 (aa11–20) epitope through HLA-A2 molecules.

STAGE OF DEVELOPMENT

Tangible material TC-1/A2 cell line available

ASSOCIATED INVENTORS
Pathology, School of Medicine
PI: T.C. WU, M.D., Ph.D.
Chien-Fu Hung, Ph.D.

ASSOCIATED PUBLICATIONS
Peng et al. 2006 “Characterization of HLA-A2-restricted HPV-16 E7-specific CD8 (+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice”.  Gene Ther. 13(1):67-77.■

CONTACT INFORMATION
Christine Joseph
Technology Analyst, Life Sciences Licensing
Johns Hopkins Technology Ventures
410-502-8355
cjoseph6@jhmi.edu

Patent Information:
Inventors:
Category(s):
For Information, Contact:
Christine Joseph
cjoseph6@jhmi.edu
410-614-0300
Save This Technology:
2017 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum